ASTRAZENECA PLC (AZN)
Clinical trial NCT06129864 updates: 1. completion date: 2030-09-12 → 2031-02-28 2. primary completion date: 2028-04-18 → 2030-04-17
Clinical trial NCT06129864 updates: 1. completion date: 2030-09-12 → 2031-02-28 2. primary completion date: 2028-04-18 → 2030-04-17
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical